We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000301:SZSEJiangsu Eastern Shenghong Co.,Ltd. Analysis

Data as of 2026-03-07 - not real-time

CN¥12.93

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock trades at CNY 12.93, sitting above its 50‑day (≈CNY 11.8) and 200‑day (≈CNY 9.8) simple moving averages but slightly below the 20‑day SMA (≈CNY 13.0), indicating a mixed short‑term bias. Momentum is neutral with an RSI of about 52, while the MACD histogram is negative and the signal line is flagged as bearish. Volume is on an increasing trend, and the price is holding above the calculated support of CNY 12.11, with resistance near CNY 14.70.
Fundamental backdrop: Earnings are currently negative (trailing EPS ‑0.12) and the forward PE is steep at ~72×, while the DCF‑derived fair value is only CNY 7.73, implying the market is pricing in a ~13% downside from today’s level. The balance sheet is heavily leveraged (debt‑to‑equity ≈398) and free cash flow is negative, though the company holds substantial cash (≈CNY 17.7 bn). A recent state approval for a 2 million‑tonne imported crude quota could boost future refining capacity and earnings, but the upside is offset by the current overvaluation and financial strain.
Overall, the stock shows bullish technical signs but is hampered by weak profitability, high leverage, and a valuation gap, making it a cautious play pending clearer earnings recovery.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price holding just above technical support
  • Bearish MACD momentum
  • Negative earnings and cash flow

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • State‑approved crude quota could lift refining margins
  • Forward EPS projection turning positive
  • Volume trend indicating growing investor interest

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Persistently high debt‑to‑equity ratio
  • DCF fair value far below current price
  • Sustained profitability challenges in a cyclical chemicals sector

Key Metrics & Analysis

Financial Health

Revenue Growth-11.90%
Profit Margin-0.62%
P/E Ratio71.8
ROE-2.05%
ROA0.61%
Debt/Equity397.81
P/B Ratio2.5
Op. Cash FlowCN¥18.9B
Free Cash FlowCN¥-1847124352

Technical Analysis

TrendBullish
RSI52.0
SupportCN¥12.11
ResistanceCN¥14.70
MA 20CN¥13.05
MA 50CN¥11.82
MA 200CN¥9.84
MACDBearish
VolumeIncreasing
Fear & Greed Index68.77

Valuation

Fair ValueCN¥7.73
Target PriceCN¥11.20
Upside/Downside-13.38%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.05
Volatility57.56%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.